Table 1 Demographic and clinical characteristics of participants
All participants (n = 38) | Subsample performing an endurance training session (n = 26) | Subsample performing a resistance training session (n = 31) | |
|---|---|---|---|
Age (years) | 53.6 ± 9.7 | 51.8 ± 8.6 | 53.5 ± 10.2 |
Habitual endurance exerciser a | |||
Yes | 18 (49%) b | 14 (54%) | 15 (50%) c |
No | 19 (51%) | 12 (46%) | 15 (50%) |
Habitual resistance exerciser a | |||
Yes | 11 (29%) | 9 (35%) | 10 (32%) |
No | 27 (31%) | 17 (65%) | 21 (68%) |
Education | |||
≤ 9 years | 1 (3%) | 1 (4%) | 1 (3%) |
9–12 years | 8 (21%) | 4 (15%) | 6 (19%) |
≥ 12 years | 29 (76%) | 21 (81%) | 24 (77%) |
Clinical stage | |||
I | 16 (42%) | 12 (46%) | 13 (42%) |
II | 20 (53%) | 12 (46%) | 17 (55%) |
III | 2 (5%) | 2 (8%) | 1 (3%) |
Treatment | |||
EC | 35 (92%) | 23 (88%) | 29 (94%) |
Docetaxel | 2 (5%) | 2 (8%) | 1 (3%) |
Kadcyla | 1 (3%) | 1 (4%) | 1 (3%) |
Before training | |||
Energy (score 0–5) | 2.9 ± 1.0 | 2.8 ± 1.2 | 2.9 ± 1.1 |
Stress (score 0–5) | 1.8 ± 0.8 | 1.8 ± 1.0 | 1.8 ± 0.9 |
Nausea (VAS 0–10) | 1.6 ± 2.0 | 1.6 ± 2.3 | 1.9 ± 2.2 |
Pain (VAS 0–10) | 0.6 ± 0.9 | 0.7 ± 1.1 | 0.4 ± 0.7 |